Recombinant trimeric HA protein immunogenicity of H5N1 avian influenza viruses and their combined use with inactivated or adenovirus vaccines

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Lin, Shih Chang ^a   Huang, Ming Hsi ^b   Tsou, Pei Chun ^a   Huang, Li Min ^c   Chong, Pele ^b   Wu, Suh Chin ^a,b  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CPG OLIGODEOXYNUCLEOTIDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; NEUTRALIZING ANTIBODY; RECOMBINANT INFLUENZA VIRUS HEMAGGLUTININ; RECOMBINANT PROTEIN; SORBITAN TRIOLEATE; SQUALENE; UNCLASSIFIED DRUG; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ;

ADENOVIRUS; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CLADISTICS; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; TREATMENT OUTCOME; VIRUS INACTIVATION; VIRUS RECOMBINANT; VIRUS STRAIN; ANIMAL; BAGG ALBINO MOUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY;

ADENOVIRIDAE; AVES; AVIAN INFLUENZA VIRUS; HEXAPODA; MUS;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C;

EID: 79957796724     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020052     Document Type: Article

References (37)

1. Salomon R, Webster RG, (2009) The influenza virus enigma. Cell 136: 402-10.
2. Horimoto T, Kawaoka Y, (2005) Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol 3: 591-600.
3. Peiris JS, de Jong MD, Guan Y, (2007) Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev 20: 243-67.
4. World Health Organization [WHO] website. Available: http://www.who.int/csr/disease/avian_influenza/country/cases_table_2011_04_21/en/index.html. Accessed 2011April 26.
5. Lin YJ, Deng MC, Wu SH, Chen YL, Cheng HC, et al. (2008) Baculovirus-derived hemagglutinin vaccine protects chickens from lethal homologous virus H5N1 challenge. J Vet Med Sci 70: 1147-52.
6. Shen S, Mahadevappa G, Oh HL, Wee BY, Choi YW, et al. (2008) Comparing the antibody responses against recombinant hemagglutinin proteins of avian influenza A (H5N1) virus expressed in insect cells and bacteria. J Med Virol 80: 1972-83.
7. Wei CJ, Xu L, Kong WP, Shi W, Canis K, et al. (2008) Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus. J Virol 82: 6200-8.
8. Cornelissen LA, de Vries RP, de Boer-Luijtze EA, Rigter A, Rottier PJ, et al. (2010) A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1. PLoS One 5: e10645.
9. Du L, Leung VH, Zhang X, Zhou J, Chen M, et al. (2011) A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses. PLoS One 6: e16555.
10. Shoji Y, Bi H, Musiychuk K, Rhee A, Horsey A, et al. (2009) Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza. Vaccine 27: 1087-92.
11. Kalthoff D, Giritch A, Geisler K, Bettmann U, Klimyuk V, et al. (2010) Immunization with plant-expressed hemagglutinin protects chickens from lethal highly pathogenic avian influenza virus H5N1 challenge infection. J Virol 84: 12002-10.
12. Chiu FF, Venkatesan N, Wu CR, Chou AH, Chen HW, et al. (2009) Immunological study of HA1 domain of hemagglutinin of influenza H5N1 virus. Biochem Biophys Res Commun 383: 27-31.
13. Song L, Zhang Y, Yun NE, Poussard AL, Smith JN, et al. (2009) Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin. Vaccine 27: 5875-84.
14. Biesova Z, Miller MA, Schneerson R, Shiloach J, Green KY, et al. (2009) Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus. Vaccine 27: 6234-8.
15. Khurana S, Verma S, Verma N, Crevar CJ, Carter DM, et al. (2011) Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets. J Virol 85: 1246-56.
16. Harbury PB, Zhang T, Kim PS, Alber T, (1993) A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants. Science 262: 1401-7.
17. Huang MH, Lin SC, Hsiao CH, Chao HJ, Yang HR, et al. (2010) Emulsified nanoparticles containing inactivated influenza virus and CpG oligodeoxynucleotides critically influences the host immune responses in mice. PLoS One 5: e12279.
18. Nkolola JP, Peng H, Settembre EC, Freeman M, Grandpre LE, et al. (2010) Breadth of neutralizing antibodies elicited by stable, homogeneous clade A and clade C HIV-1 gp140 envelope trimers in guinea pigs. J Virol 84: 3270-9.
19. Harbury PB, Kim PS, Alber T, (1994) Crystal structure of an isoleucine-zipper trimer. Nature 371: 80-3.
20. Hernandez Alvarez B, Hartmann MD, Albrecht R, Lupas AN, Zeth K, et al. (2008) A new expression system for protein crystallization using trimeric coiled-coil adaptors. Protein Eng Des Sel 21: 11-8.
21. Bosch BJ, Bodewes R, de Vries RP, Kreijtz JH, Bartelink W, et al. (2010) Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets. J Virol 84: 10366-74.
22. Weldon WC, Wang BZ, Martin MP, Koutsonanos DG, Skountzou I, et al. (2010) Enhanced immunogenicity of stabilized trimeric soluble influenza hemagglutinin. PLoS One 5: e12466.
23. Loeffen WL, de Vries RP, Stockhofe N, van Zoelen-Bos D, Maas R, et al. (2011) Vaccination with a soluble recombinant hemagglutinin trimer protects pigs against a challenge with pandemic (H1N1) 2009 influenza virus. Vaccine 29: 1545-50.
24. Boudko SP, Londer YY, Letarov AV, Sernova NV, Engel J, et al. (2002) Domain organization, folding and stability of bacteriophage T4 fibritin, a segmented coiled-coil protein. Eur J Biochem 269: 833-41.
25. Guthe S, Kapinos L, Moglich A, Meier S, Grzesiek S, et al. (2004) Very fast folding and association of a trimerization domain from bacteriophage T4 fibritin. J Mol Biol 337: 905-15.
26. Treanor JJ, Wilkinson BE, Masseoud F, Hu-Primmer J, Battaglia R, et al. (2001) Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. Vaccine 19: 1732-7.
27. King JC Jr, Cox MM, Reisinger K, Hedrick J, Graham I, et al. (2009) Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months. Vaccine 27: 6589-94.
28. Wang CC, Chen JR, Tseng YC, Hsu CH, Hung YF, et al. (2009) Glycans on influenza hemagglutinin affect receptor binding and immune response. Proc Natl Acad Sci U S A 106: 18137-42.
29. Ikeno D, Kimachi K, Kudo Y, Goto S, Itamura S, et al. (2009) A prime-boost vaccination of mice with heterologous H5N1 strains. Vaccine 27: 3121-5.
30. Sabarth N, Howard MK, Savidis-Dacho H, van Maurik A, Barrett PN, et al. (2010) Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model. Vaccine 28: 650-6.
31. Gerhard W, Yewdell J, Frankel ME, Webster R, (1981) Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 290: 713-7.
32. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W, (1982) The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31: 417-27.
33. Kaverin NV, Rudneva IA, Govorkova EA, Timofeeva TA, Shilov AA, et al. (2007) Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J Virol 81: 12911-7.
34. Li J, Wang Y, Liang Y, Ni B, Wan Y, et al. (2009) Fine antigenic variation within H5N1 influenza virus hemagglutinin's antigenic sites defined by yeast cell surface display. Eur J Immunol 39: 3498-510.
35. Wang TT, Tan GS, Hai R, Pica N, Petersen E, et al. (2010) Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog 6: e1000796.
36. Kim JH, Skountzou I, Compans R, Jacob J, (2009) Original antigenic sin responses to influenza viruses. J Immunol 183: 3294-301.
37. Nefkens I, Garcia JM, Ling CS, Lagarde N, Nicholls J, et al. (2007) Hemagglutinin pseudotyped lentiviral particles: characterization of a new method for avian H5N1 influenza sero-diagnosis. J Clin Virol 39: 27-33.